Ambrisentan: a guide to its use in pulmonary arterial hypertension

被引：0
|
作者：
机构：
来源：
Drugs & Therapy Perspectives | 2009年 / 25卷 / 7期
关键词：
D O I：
10.2165/0042310-200925070-00001
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1 / 5
页数：4
相关论文
共 50 条
  • [1] Ambrisentan in pulmonary arterial hypertension: a guide to its use in the EU
    Behr J.
    Lyseng-Williamson K.A.
    Drugs & Therapy Perspectives, 2016, 32 (2) : 50 - 59
  • [2] Ambrisentan: A guide to its use in pulmonary arterial hypertension in the EU
    Behr J.
    Lyseng-Williamson K.A.
    Drugs & Therapy Perspectives, 2014, 30 (7) : 231 - 240
  • [3] Erratum to: Ambrisentan: a guide to its use in pulmonary arterial hypertension in the EU
    Jürgen Behr
    Katherine A. Lyseng-Williamson
    Drugs & Therapy Perspectives, 2014, 30 (8) : 302 - 302
  • [4] Ambrisentan: a review of its use in pulmonary arterial hypertension
    Rivera-Lebron, Belinda N.
    Risbano, Michael G.
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2017, 11 (06) : 233 - 244
  • [5] An update on the use of ambrisentan in pulmonary arterial hypertension
    D'Alto, Michele
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2012, 6 (06) : 331 - 343
  • [6] Ambrisentan: A guide to its use in pulmonary arterial hypertension classified as WHO functional class II or III
    Behr J.
    Lyseng-Williamson K.A.
    Drugs & Therapy Perspectives, 2011, 27 (1) : 1 - 8
  • [7] Ambrisentan ± tadalafil in WHO functional class II/III pulmonary arterial hypertension: a guide to its use in the EU
    Lyseng-Williamson K.A.
    Behr J.
    Drugs & Therapy Perspectives, 2018, 34 (7) : 289 - 299
  • [8] AMBRISENTAN AND ITS ROLE IN THE MANAGEMENT OF PULMONARY ARTERIAL HYPERTENSION
    Maclntyre, Lain M.
    Dhaun, Neeraj
    Goddard, Jane
    Webb, David J.
    DRUGS OF TODAY, 2008, 44 (12) : 875 - 885
  • [9] Ambrisentan for pulmonary arterial hypertension
    Rubin, Lewis J.
    Dufton, Christopher
    Gerber, Michael J.
    FUTURE CARDIOLOGY, 2005, 1 (04) : 425 - 432
  • [10] Sitaxentan: a guide to its use in pulmonary arterial hypertension
    Drugs & Therapy Perspectives, 2007, 23 (9) : 5 - 8
12345